US

Entrée Capital wraps up sophomore Israel-focused early-stage fund at $80 mln

Entrée Capital has closed its second Israeli-focused early-stage fund at $80 million. Also, the venture firm has hired Ran Achituv as a managing partner and promoted Eran Bielski to general partner. Entrée Capital has offices in London, San Francisco and Herzliya, Israel.

Mobile performance advertising startup Moloco scores $11 mln Series B

Moloco, a mobile performance advertising startup, has secured $11 million in Series B funding. Samsung Ventures and Draper Athena led the round with participation from Mirae Asset Management, Smilegate Investment and KTB Ventures.

Stem cell company Forever Labs attracts $2 mln

Forever Labs, a company that banks young adult stem cells, has secured $2 million in funding. The investors included Northwestern Mutual, Silicon Badia Ventures, Babel Ventures and DogVacay CEO and founder Aaron Hirschhorn.

Fifth Wall Ventures raises $60 mln toward its Fifth Wall Ventures Retail Fund

Fifth Wall Ventures has raised $60 million toward a $200 million Fifth Wall Ventures Retail Fund, according to a filing with the SEC.

Localize.city raises $8 mln Series A

Localize.city said it raised a Series A round of $8 million in a deal led by entrepreneur Avigdor Willenz and investor Zvi Limon.

Presidio View collects $2.6 mln for cannabis investments

Presidio View Capital Partners, a venture firm that invests in the cannabis industry, has raised $2.6 million for its inaugural fund, according to an SEC filing. The target is $15 million, according to Michael Clifton, co-founder of Presidio View Capital. The hard cap on Fund I is $25 million, the Form D said.

Drishti raises $10 mln from Emergence Capital, Andreessen Horowitz, Benhamou Global Ventures

Drishti said it raised $10 million of Series A funding in a round led by Emergence Capital and joined by existing investors Andreessen Horowitz and Benhamou Global Ventures.

Fairygodboss picks up $3 mln

Fairygodboss, a career community for women, has raised $3 million in funding, according to an announcement on its site. The lead investor was GSV Acceleration.

VC-backed Evelo Biosciences goes public

Cambridge, Massachusetts-based Evelo Biosciences, a biotech company, has raised $85 million for its IPO after pricing its 5.3 million shares at $16 per share. The stock began trading May 9, 2018 on the NASDAQ under the ticker symbol "EVLO." Morgan Stanley, Cowen and BMO Capital Markets are the lead underwriters. Evelo's pre-IPO backers included Flagship Pioneering, GV, Celgene, Mayo Clinic and Alexandria Venture Investments.

KeyedIn nets $15 mln Series C

Minneapolis-based KeyedIn, a maker of cloud ERP and project management software, has secured $15 million in Series C financing. Arrowroot Capital led the round.